Drug Shortage Report for RABAVERT

Last updated on 2025-05-02 History
Report ID 240661
Drug Identification Number 02267667
Brand name RABAVERT
Common or Proper name Inactivated rabies virus (Flury LEP)
Company Name BAVARIAN NORDIC AS
Market Status MARKETED
Active Ingredient(s) INACTIVATED RABIES VIRUS
Strength(s) 2.5UNIT
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 1 RabAvert vial and 1 Diluent prefilled syringe
ATC code J07BG
ATC description VIRAL VACCINES
Reason for shortage Demand increase for the drug.
Anticipated start date 2024-10-17
Actual start date 2024-10-17
Estimated end date 2025-05-02
Actual end date 2025-05-01
Shortage status Resolved
Updated date 2025-05-02
Company comments Shortage ended for the private market
Health Canada comments
Tier 3 Status No
Contact Address PHILIP HEYMANS ALLE 3
HELLERUP, --
DENMARK 2900
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v20 2025-05-02 English Compare
v19 2025-05-01 French Compare
v18 2025-05-01 English Compare
v17 2025-04-25 French Compare
v16 2025-04-25 English Compare
v15 2025-04-25 French Compare
v14 2025-04-25 French Compare
v13 2025-04-25 English Compare
v12 2025-04-25 English Compare
v11 2025-04-14 French Compare
v10 2025-04-14 English Compare
v9 2025-02-02 French Compare
v8 2025-02-02 English Compare
v7 2025-01-06 English Compare
v6 2025-01-05 French Compare
v5 2025-01-05 English Compare
v4 2024-10-18 French Compare
v3 2024-10-18 English Compare
v2 2024-10-18 French Compare
v1 2024-10-18 English Compare

Showing 1 to 20 of 20